THC and CBD: what the names and numbers mean
Identify each cannabinoid, read the amount and ratio in the right order, and keep a formula description separate from an effect claim.

Begin with the ingredient names
THC and CBD are names of different cannabinoids. If a label lists both, each amount belongs to its own ingredient. Adding their milligrams does not give you a new THC total. The same discipline becomes useful when CBN or CBG joins the list: identify the letters before comparing the numbers.
FDA's cannabis questions and answers identify delta-9 tetrahydrocannabinol, commonly called THC, and cannabidiol, commonly called CBD, among the better-known compounds in cannabis. These names identify substances within a much broader plant and product discussion. They do not, by themselves, describe a complete retail formulation or establish that a product is appropriate for an individual. FDA: cannabis and cannabinoid questions
A product can contain one or more named cannabinoids alongside food ingredients, liquid carriers or other materials. Keep the ingredient names from the actual label rather than replacing them with a general cannabis shorthand. That is especially important when a product family includes different formats, amounts or combinations under similar branding.
For example, a product name containing CBD does not, on its own, provide the amount of CBD or establish that no THC is present. The full ingredient and cannabinoid information has to answer those questions. Keep an undisclosed quantity unresolved rather than treating the familiar name as a complete analysis.
Begin with the ingredient names.
A milligram is an amount, not an experience
NIST's metric-prefix guidance establishes milli as one thousandth. A milligram is a unit of mass. On a cannabinoid label, the relevant question is a mass of which substance and in what quantity of product. The same unit can describe different ingredients without making those ingredients interchangeable. NIST: metric prefixes
A hypothetical statement of 2 mg THC and 4 mg CBD does not mean 6 mg THC. Adding them would give a combined stated cannabinoid mass, which answers a different question. Keep the individual quantities even when a package also presents a combined figure. Removing their names loses the distinction that makes the numbers useful.
The serving basis is just as important. A figure per bottle and a figure per serving can use the same unit while describing different quantities of product. A bare milligram number cannot identify the denominator. Preserve the exact wording before comparing it with another product or using it in a calculation.
A ratio describes a relationship
Papa & Barkley's 30:1 Releaf Tincture page identifies a CBD-dominant formula and separately lists CBD and THC amounts for its bottle formats. The maker's 30 mL example gives 900 mg CBD and 30 mg THC. That is a stated relationship between two ingredients, with batch variation acknowledged by the manufacturer. Papa & Barkley: 30:1 Releaf Tincture
Write ratios in words when you save them: CBD to THC or THC to CBD. Reversing the names changes the description. A ratio alone also cannot supply absolute amounts. Several hypothetical products could share a 2:1 relationship while containing different totals, concentrations and other ingredients. Retain those quantities separately rather than making the ratio stand in for them.
The same caution applies to words such as balanced. They may describe a manufacturer's product positioning or ingredient relationship. They do not automatically define a measured experience. Look for the maker's actual explanation and keep it separate from the numerical description of the formula.
CBD does not settle a combination's effects
In a 2023 controlled brownie study, 18 adults received placebo, THC alone or THC with a much larger CBD amount under defined conditions. The combination produced stronger reported effects and more impairment on some tasks. A drug-probe cocktail and the specific amounts and preparation limit interpretation. The study does not predict the response to a retail oil, drink or gummy. Zamarripa et al. (2023): oral THC and CBD
Its relevance here is the limit of a blanket rule. The presence of CBD cannot simply be translated into a promise that a THC-containing product will feel gentler. Keep the actual amounts and preparation with the finding, rather than promoting one experiment into a universal description of every cannabinoid combination.
Likewise, an ingredient definition cannot establish that a finished product is free of risks or that someone can drive after using it. A glossary explains the language needed to ask a question. An individual response, a health outcome and legal availability require information beyond the abbreviations on a package.
Translate the label into a complete sentence
For a fictional example, “2 mg THC and 4 mg CBD per can” states two ingredient amounts on one container basis. “CBD to THC, two to one” describes their ratio in the opposite written order. Both can describe that example, but the order of the names has to travel with the ratio.
A different can could have the same ratio with different quantities. That is why the ratio belongs beside the separate amounts, not in place of them. When a bottle is involved, reading CBD-to-THC ratios on drops adds the concentration and volume questions that a ratio cannot answer.
You should be able to identify the cannabinoid, its amount and the amount of product represented without describing an expected feeling. That is the job of this glossary. Whether a formulation has a particular effect or is appropriate for someone requires evidence and context beyond the initials.
Sources & review
FDA/NIST support identity and units. Maker quantities are attributed, and the 18-adult 2023 brownie study is retained with its high-CBD and drug-probe conditions rather than treated as a retail effect prediction.
- FDA: cannabis and cannabinoid questions
Question 1 identifies THC and CBD. No nationwide retail availability, dosing or safety claim is inferred.
- NIST: metric prefixes
Unit-prefix definitions; calculations in these articles are our explicitly hypothetical examples.
- Papa & Barkley: 30:1 Releaf Tincture
Maker's stated ingredients, bottle formats and cannabinoid amounts; batch-specific label remains important. Effects and administration suggestions are not adopted.
- Zamarripa et al. (2023): oral THC and CBD
Eighteen-adult crossover brownie trial with high CBD exposure and a drug-probe cocktail; not a retail-product effect prediction. DOI: 10.1001/jamanetworkopen.2022.54752.



